If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> <br /> SPECIAL DIGITAL SUPPLEMENT<br /> SPONSORED CONTENT BY GUERBET<br /> THE MAGAZINE OF DISTINCTION IN RADIOLOGY<br /> WHY TWO IMAGING<br /> CENTERS CHANGED THEIR<br /> CONTRAST MEDIUM<br /> Switching<br /> to Dotarem®<br /> Why Two Imaging Centers Changed<br /> Their Contrast Medium<br /> IMPORTANT SAFETY INFORMATION1<br /> WARNING: NEPHROGENIC SYSTEMIC FIBROSIS (NSF)<br /> Gadolinium-based contrast agents (GBCAs) increase the risk for NSF among patients with impaired elimination of the drugs. Avoid use of<br /> GBCAs in these patients unless the diagnostic information is essential and not available with non-contrasted MRI or other modalities.<br /> NSF may result in fatal or debilitating fibrosis affecting the skin, muscle and internal organs.<br /> · The risk for NSF appears highest among patients with:<br /> o Chronic, severe kidney disease (GFR < 30 mL/min/1.73m2), or<br /> o Acute kidney injury.<br /> · Screen patients f<a title="July 2021 - Guerbet Digital Supplement page 1" href="https://secure.viewer.zmags.com/publication/23bcf9a9?page=1"> </a> <a title="July 2021 - Guerbet Digital Supplement page 2" href="https://secure.viewer.zmags.com/publication/23bcf9a9?page=2"> SPECIAL DIGITAL SUPPLEMENT SPONSORED CONTENT BY G</a> <a title="July 2021 - Guerbet Digital Supplement page 3" href="https://secure.viewer.zmags.com/publication/23bcf9a9?page=3"> Switching to Dotarem® Why Two Imaging Centers Cha</a> <a title="July 2021 - Guerbet Digital Supplement page 4" href="https://secure.viewer.zmags.com/publication/23bcf9a9?page=4"> Interview with Ryan Garland, MHA, BS, RT (R), Sys</a> <a title="July 2021 - Guerbet Digital Supplement page 5" href="https://secure.viewer.zmags.com/publication/23bcf9a9?page=5"> Interview with Mark L. Winkler, MD, President of </a> <a title="July 2021 - Guerbet Digital Supplement page 6" href="https://secure.viewer.zmags.com/publication/23bcf9a9?page=6"> IMPORTANT SAFETY INFORMATION CONT.1 Indication</a> <a title="July 2021 - Guerbet Digital Supplement page 7" href="https://secure.viewer.zmags.com/publication/23bcf9a9?page=7"> MRI Interconnected Solutions CONTRAST AGENT I</a>